2025 AAN Annual Meeting
2025 AAN
Annual Meeting
April 5-9, San Diego Convention Center | Booth #2113
April 5-9, San Diego Convention Center, Booth #2113
Join us in our booth for drinks and appetizers
during the Exhibitor Networking Crawl!
Join us in our booth for drinks
and appetizers during the
Exhibitor Networking Crawl!
Monday, April 7th
4-6 PM PT
Booth #2113 | Exhibit Hall
Monday, April 7th
4-6 PM
PT
Booth #2113
Exhibit Hall
Praxis to be at AAN Annual Meeting Lorem ipsum dolor sit amet adipiscing aleum title goes here for the press release
BOSTON, March 04, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be participating in five upcoming investor conferences:
Poster Presentations
| Date and Time (PT) | Poster Number | Poster Title | Poster Session |
|---|---|---|---|
| Saturday, April 511:45 AM – 12:45 PM | 5-011 Neighborhood 5 |
Spotlight on Essential Tremor Management and Impact: Results from an Online Survey Capturing HCP and Patient Perspectives of Disease Burden | P1: Movement Disorders: Essential Tremor and Other Tremor Disorders |
| Saturday, April 511:45 AM – 12:45 PM | 5-012 Neighborhood 5 |
Characteristics of Adult Essential Tremor Patients Seeking Participation in a Decentralized US Clinical Trial: Pre-screener Findings from the Essential3 Program Evaluating Efficacy and Safety of Ulixacaltamide | P1: Movement Disorders: Essential Tremor and Other Tremor Disorders |
| Monday, April 78:00 AM – 9:00 AM | 9-012 Neighborhood 9 |
Epilepsy Monitoring of Prospective Seizure Observations with Electronic Records (EMPOWER): An Observational Study Designed to Better Understand the Patient Journey | P5: Epilepsy/Clinical Neurophysiology (EEG): Neuromodulation Devices and Seizure Tracking |
| Wednesday, April 98:00 AM – 9:00 AM | 4-006 Neighborhood 4 |
Updates from the First-in-human Phase 1 Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Food Effect of Vormatrigine in Healthy Participants | P11: Emerging Science |
In Booth Speaker Showcase
Revolutionizing Therapies for CNS Disorders
Speaker Faculty
Orrin Devinsky, MD
NYU Langone Comprehensive Epilepsy Center, NY
Jacqueline French, MD
NYU Langone Comprehensive Epilepsy Center, NY
Kashayar Dashtipour, MD, PhD
Loma Linda University School of Medicine, CA
Alberto Espay, MD
Cincinnati College of Medicine, OH
Monique Giroux, MD
Praxis Precision Medicines, MA
In Booth Speaker Showcase
Revolutionizing Therapies for CNS Disorders
Schedule of Events
Sunday, April 6
Monday, April 7
Tuesday, April 8
Wednesday, April 9
Sunday, April 6
| Time | Speaker | Presentation Title |
|---|---|---|
| 1:30 pm – 1:50 pm | Dr. Alberto Espay | Essential Tremor: Hidden Burden and Current Treatment Challenges |
| Question/Answer Time | ||
| 2:00 pm – 2:20 pm | Dr. Jacqueline French | EMPOWER: An Observational Study Designed to Better Understand the Patient Journey in Epilepsy |
| Question/Answer Time | ||
| 2:30 pm – 2:50 pm | Dr. Monique Giroux | Ulixacaltamide: The Journey to Develop a New Essential Tremor Therapy |
| Question/Answer Time | ||
| 3:00 pm – 3:20 pm | Dr. Jacqueline French | EMPOWER: An Observational Study Designed to Better Understand the Patient Journey in Epilepsy |
| Question/Answer Time | ||
| 3:30 pm Adjournment | ||
Monday, April 7
| Time | Speaker | Presentation Title |
|---|---|---|
| 1:30 pm – 1:50 pm | Dr. Alberto Espay | Essential Tremor: Hidden Burden and Current Treatment Challenges |
| Question/Answer Time | ||
| 2:00 pm – 2:20 pm | Dr. Jacqueline French | EMPOWER: An Observational Study Designed to Better Understand the Patient Journey in Epilepsy |
| Question/Answer Time | ||
| 2:30 pm – 2:50 pm | Dr. Monique Giroux | Ulixacaltamide: The Journey to Develop a New Essential Tremor Therapy |
| Question/Answer Time | ||
| 3:00 pm – 3:20 pm | Dr. Orrin Devinsky | Maximizing Impact on Disease and the Future of Treatment for Epilepsy |
| Question/Answer Time | ||
| 3:30 pm Adjournment | ||
Tuesday, April 8
| Time | Speaker | Presentation Title |
|---|---|---|
| 1:30 pm – 1:50 pm | Dr. Kashayar Dashtipour | Essential Tremor: Hidden Burden and Current Treatment Challenges |
| Question/Answer Time | ||
| 2:00 pm – 2:20 pm | Dr. Orrin Devinsky | Maximizing Impact on Disease and the Future of Treatment for Epilepsy |
| Question/Answer Time | ||
| 2:30 pm – 2:50 pm | Dr. Monique Giroux | Ulixacaltamide: The Journey to Develop a New Essential Tremor Therapy |
| Question/Answer Time | ||
| 3:00 pm – 3:20 pm | Dr. Orrin Devinsky | Maximizing Impact on Disease and the Future of Treatment for Epilepsy |
| Question/Answer Time | ||
| 3:30 pm Adjournment | ||
Wednesday, April 9
| Time | Speaker | Presentation Title |
|---|---|---|
| 1:30 pm – 1:50 pm | Dr. Kashayar Dashtipour | Essential Tremor: Hidden Burden and Current Treatment Challenges |
| Question/Answer Time | ||
| 2:00 pm – 2:20 pm | Dr. Monique Giroux | Ulixacaltamide: The Journey to Develop a New Essential Tremor Therapy |
| Question/Answer Time | ||
| 2:30 pm Adjournment | ||
| Day 1 – Sunday April 6 | ||
| Time | Presenter | Presentation Title (TBC) |
|---|---|---|
| 1:30 pm - 1:50 pm | Dr. Alberto Espay | Lorem ipsum dolor sit amet adipiscing aleum nonsectetur alit deu alis presentum lorem dolor sit amet. |
| Question/Answer Time | ||
| 2:00 pm - 2:20 pm | Dr. Jacqueline French | Lorem ipsum dolor sit amet adipiscing aleum nonsectetur alit deu alis presentum lorem dolor sit amet. |
| Question/Answer Time | ||
| 2:30 pm - 2:50 pm | Dr. Monique Giroux | Lorem ipsum dolor sit amet adipiscing aleum nonsectetur alit deu alis presentum lorem dolor sit amet. |
| Question/Answer Time | ||
| 3:00 pm - 3:20 pm | Dr. Jacqueline French | Lorem ipsum dolor sit amet adipiscing aleum nonsectetur alit deu alis presentum lorem dolor sit amet. |
| Question/Answer Time | ||
| 3:30 pm Adjournment | ||
